SCIENTIFIC PUBLICATIONS CDMO - pluri-biotech.com

SCIENTIFIC
PUBLICATIONS

CDMO Related Publications

22

Oct

2021

Key considerations and risk management best practice for placenta-derived cell therapy raw materials

20

Nov

2020

Industrializing allogeneic cell therapy bioprocessing – devising streamlined solutions to complex challenges

06

Nov

2018

Changing the ‘Art’ of Growing Cells into an Industrialized Platform for Commercial-Scale Manufacturing

20

May

2015

Concise Review: Process Development Considerations for Cell Therapy

01

Apr

2015

Foundation Elements for Cell Therapy Smart Scaling

Loading...

Pluri Science Related Publications

01

Feb

2024

PACE: randomized, controlled, multicentre, multinational, phase III study of PLX-PAD for critical limb ischaemia in patients unsuitable for revascularization: randomized clinical trial

08

Aug

2023

Placental expanded mesenchymal-like cells (PLX-R18) for poor graft function after hematopoietic cell transplantation: A phase I study

28

Sep

2022

Pre-Administration of PLX-R18 Cells Protects Mice from Radiation-Induced Hematopoietic Failure and Lethality

21

Jun

2022

Placenta-Derived Mesenchymal-like Adherent Stromal Cells as an Effective Cell Therapy for Cocaine Addiction in a Rat Model

02

Mar

2022

A functional corona around extracellular vesicles enhances angiogenesis, skin regeneration and immunomodulation

08

Feb

2022

Intramuscular and intratendinous placenta-derived mesenchymal stromal-like cell treatment of a chronic quadriceps tendon rupture

14

Jan

2021

Perinatal Cells: A Promising COVID-19 Therapy?

18

Sep

2020

Placenta-Derived Cell Therapy to Treat Patients With Respiratory Failure Due to Coronavirus Disease 2019

14

Jan

2020

Mesenchymal Stromal Cells from Fetal and Maternal Placenta Possess Key Similarities and Differences: Potential Implications for Their Applications in Regenerative Medicine

20

Aug

2019

Use of Human Placenta-Derived Cells in a Preclinical Model of Tendon Injury

25

Jan

2019

PLX-PAD Cell Treatment of Critical Limb Ischaemia: Rationale and Design of the PACE Trial

05

Nov

2018

Placenta-Derived Adherent Stromal Cell Therapy for Hematopoietic Disorders: A Case Study of PLX-R18

22

Oct

2018

Rescue from lethal acute radiation syndrome (ARS) with severe weight loss by secretome of intramuscularly injected human placental stromal cells

10

Oct

2018

Immunomodulatory placental-expanded, mesenchymal stromal cells improve muscle function

27

Feb

2018

Posttransplant Intramuscular Injection of PLX-R18 Mesenchymal-Like Adherent Stromal Cells Improves Human Hematopoietic Engraftment in A Murine Transplant Model

12

Jan

2018

Human Placental-Derived Adherent Stromal Cells Co-Induced with TNF-α and IFN-γ Inhibit Triple-Negative Breast Cancer in Nude Mouse Xenograft Models

06

Dec

2017

Placenta-derived PLX-PAD mesenchymal-like stromal cells are efficacious in rescuing blood flow in hind limb ischemia mouse model by a dose- and site-dependen

06

Dec

2017

Placenta-Derived Adherent Stromal Cells Improve Diabetes Mellitus-Associated Left Ventricular Diastolic Performance

10

Feb

2016

Human placenta-derived stromal cells decrease inflammation, placental injury and blood pressure in hypertensive pregnant mice

12

Dec

2015

Human PLacental eXpanded (PLX) mesenchymal-like adherent stromal 2 cells confer neuroprotection to nerve growth factor (NGF)-differentiated 3 PC12 cells exposed to ischemia by secretion of IL-6 and VEGF

Loading...

NEXT

BACK TO CDMO